Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED M&A Activity 2024

Sep 12, 2024

62616_rns_2024-09-12_a435fe0f-5545-4954-bd8e-0ffb42edfa52.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [136 x 44] intentionally omitted <==

September 12, 2024

BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 BSE Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 NSE Scrip Code: STAR

Dear Madam/ Sirs,

Sub: Update on Scheme of Amalgamation of Strides Alathur Private Limited (formerly known as Vivimed Life Sciences Private Limited) into the Company.

This has reference to our update of August 14, 2024, intimating approval of the Scheme by the Hon’ble National Company Law Tribunal, Mumbai Bench (NCLT) vide their Order dated on August 13, 2024.

We wish to further inform you that Strides Alathur and Strides Pharma Science have completed filing of certified copies of the NCLT Order with the Registrar of Companies, Mumbai, Ministry of Corporate Affairs, Government of India.

Consequently, the Scheme has become effective September 12, 2024 with an Appointed Date of April 1, 2023.

Pursuant to Scheme becoming effective:

  • 1) Strides Alathur Private Limited stands dissolved without winding up; &

  • 2) Authorized Share Capital of Strides Pharma Science Limited increases from Rs. 1,88,37,00,000/constituting 18,83,70,000 equity shares of Rs. 10 each to Rs. 2,18,37,00,000/- constituting 21,83,70,000 equity shares of Rs. 10 each.

You are requested to take the same on record.

Thanks & Regards, For Strides Pharma Science Limited,

MANJULA R

Digitally signed by MANJULA R Date: 2024.09.12 18:23:55 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

==> picture [505 x 51] intentionally omitted <==